Komori

2026年3月期 第2四半期(中間期)決算説明資料

Results presentationFirst half, FY ending Mar 2026Published 2025-11-13 15:30

2026年3月期第2四半期は、売上高・各利益が前年同期を上回り、過去最高を更新した。通期業績予想は、診療数の増加や生産性向上を背景に上方修正された一方、成長投資に伴う約1.7億円の費用増を主に第4四半期に見込んでいる。

Contents of this document

Earnings presentationSecond quarter (interim period) of the fiscal year ending March 20268 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥3,033 million+18.1%
Operating profit¥591 million+68.4%
Ordinary income¥589 million+67.5%
Net income¥413 million+70.2%
Gross Profit Margin39.9%
Operating profit margin19.5%
Selling, general and administrative expenses¥619 million
Results for the three months of the current quarter
Net Sales
¥1,560 million
Operating profit margin
21.3%
Full-year earnings forecast
Net Sales
¥6,100 million
Operating profit
¥1,040 million
Ordinary income
¥1,030 million
Profit attributable to owners of the parent
¥730 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales49.7%
Operating profit56.8%
Ordinary income57.3%
Profit attributable to owners of the parent56.6%
Number of initial consultations52.3%
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Revenue increase
¥464 million
Personnel Expenses
¥94 million
Facilities and IT
¥60 million
Depreciation and amortization
¥18 million
Other
¥51 million
New initiatives
  • Renovation of Nagoya Hospital
  • 福岡への新拠点展開
  • 次世代型新電子カルテシステムの導入
  • AIを活用した診療支援・画像診断支援
  • 動物医療インテリジェンスプラットフォーム構想
  • グループ共同CRM・マーケティング施策
  • 高度医療・献血の認知向上を目的とした啓発プロジェクト
Key KPIsA metric the company considers important as a management benchmark.
  • Number of initial consultations (referrals)5,519 transactions
  • Number of affiliated hospitals4,716 facilities
    Year on year against the same period last year+165施設
  • Affiliated hospital ratio36.7 %
    Year on year against the same period last year+0.5 percentage points year on year
  • Number of veterinarians99 people
  • EBITDA¥900 million
    Year on year against the same period last year+41.0%
Segment results
Secondary Veterinary Care Services
Net Sales
¥2,204 million
Year on year against the same period last year+20.0%
Diagnostic Imaging Services
Net Sales
¥315 million
Year on year against the same period last year+17.9%
動物用医療機器・健康管理機器のレンタル・販売
Net Sales
¥507 million
Year on year against the same period last year+10.3%
Medium-term management plan targets
Hospital revenue
Fiscal year ending March 2026¥4,450 million
Fiscal year ending March 2027¥4,550 million
Consolidated revenue
Fiscal year ending March 2026¥6,100 million
Fiscal year ending March 2027¥6,200 million
Consolidated operating profit
Fiscal year ending March 2026¥1,040 million
Fiscal year ending March 2027¥1,040 million
ROE
Fiscal year ending March 202616.3%
Fiscal year ending March 202714% or higher
Financial targets
ROE
Fiscal year ending March 202616.3%
Fiscal year ending March 202714% or higher
Risk amount incorporated into the outlookThe amount representing the range of variation the company expects in its forecast.
約170百万円
DetailsQ3~Q4の投資拡大に伴う費用増。約7割が一時コスト
Number of employees
Number of veterinarians99 people
Changes and hiring plans during the period新卒採用は好調、中途採用も強化中
Contents of this document
ItemDetails
Document typeEarnings presentation
Fiscal Period CoveredSecond quarter (interim period) of the fiscal year ending March 2026
Net Sales¥3,033 million (YoY +18.1%)
Operating profit¥591 million (YoY +68.4%)
Ordinary income¥589 million (YoY +67.5%)
Net income¥413 million (YoY +70.2%)
Gross Profit Margin39.9%
Operating profit margin19.5%
Selling, general and administrative expenses¥619 million
Results for the three months of the current quarterNet Sales ¥1,560 million / Operating profit margin 21.3%
Full-year earnings forecastNet Sales ¥6,100 million / Operating profit ¥1,040 million / Ordinary income ¥1,030 million / Profit attributable to owners of the parent ¥730 million
Progress against full-year forecastNet Sales 49.7% / Operating profit 56.8% / Ordinary income 57.3% / Profit attributable to owners of the parent 56.6% / Number of initial consultations 52.3%
Segment resultsSecondary Veterinary Care Services Net Sales ¥2,204 million / Year on year against the same period last year +20.0% / Profit Not disclosed / Diagnostic Imaging Services Net Sales ¥315 million / Year on year against the same period last year +17.9% / Profit Not disclosed / 動物用医療機器・健康管理機器のレンタル・販売 Net Sales ¥507 million / Year on year against the same period last year +10.3% / Profit Not disclosed
Breakdown of Factors Affecting the ChangeRevenue increase ¥464 million / Personnel Expenses ¥94 million / Facilities and IT ¥60 million / Depreciation and amortization ¥18 million / Other ¥51 million
Key KPIsIndicator name Number of initial consultations (referrals) / Value 5,519 transactions / Year on year against the same period last year Not disclosed, Indicator name Number of affiliated hospitals / Value 4,716 facilities / Year on year against the same period last year +165施設, Indicator name Affiliated hospital ratio / Value 36.7 % / Year on year against the same period last year +0.5 percentage points year on year, Indicator name Number of veterinarians / Value 99 people / Year on year against the same period last year Not disclosed, Indicator name EBITDA / Value ¥900 million / Year on year against the same period last year +41.0%
Number of employeesNumber of veterinarians 99 people / Changes and hiring plans during the period 新卒採用は好調、中途採用も強化中
Risk amount incorporated into the outlookAmount 約170百万円 / Details Q3~Q4の投資拡大に伴う費用増。約7割が一時コスト
Medium-term management plan targetsHospital revenue Fiscal year ending March 2026 ¥4,450 million / Fiscal year ending March 2027 ¥4,550 million / Consolidated revenue Fiscal year ending March 2026 ¥6,100 million / Fiscal year ending March 2027 ¥6,200 million / Consolidated operating profit Fiscal year ending March 2026 ¥1,040 million / Fiscal year ending March 2027 ¥1,040 million / ROE Fiscal year ending March 2026 16.3% / Fiscal year ending March 2027 14% or higher
Financial targetsROE Fiscal year ending March 2026 16.3% / Fiscal year ending March 2027 14% or higher
New initiativesRenovation of Nagoya Hospital, 福岡への新拠点展開, 次世代型新電子カルテシステムの導入, AIを活用した診療支援・画像診断支援, 動物医療インテリジェンスプラットフォーム構想, グループ共同CRM・マーケティング施策, 高度医療・献血の認知向上を目的とした啓発プロジェクト
Items this document does not state (11)
Self-assessment against the planUnit price and quantity metricsNumber of stores and locationsAssumptions Underlying the Business OutlookAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareQ&A topics

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

2026年3月期 第2四半期(中間期)決算説明資料 | Japan Animal Referral Medical Center Co.,Ltd. (6039) timely disclosure | Komori